TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04848402

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: On-Body Delivery System (OBDS)/Multiple Bolus Injector
Description: Used to administer placebo SC.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Single Auto Injector
Description: Used to administer placebo SC.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Administered SC.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Administered SC.
Study: NCT05807126

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo biopsies

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo collection of blood samples

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Magrolimab
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Olaparib
Description: Given PO
Study: NCT04381975

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Move in Mind Program
Description: Each of the six Move in Mind sessions will take place once a week for approximately 1.5 hours, with 12-17 individuals participating per class. The material and exercises taught will include physical floor exercises, breathing exercises, as well as awareness training.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: 6 Week Waitlist Control
Description: The waitlist control group will receive the Move in Mind program after 6 weeks.
Study: NCT05608213

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Lenvatinib Plus I-125 Seed Brachytherapy
Description: Lenvatinib (body weight ≥ 60 kg, 12mg P.O. QD; body weight \< 60 kg, 8mg P.O. QD) will be administered to the patients. Iodion-125 seeds will be implanted into the the target lesions (viable intrahepatic tumor and/or vascular tumor thrombus) under CT guidance according to the pre-operative planning within 7 days after lenvatinib administration. Iodion-125 seeds implantation can be repeated on demand during follow-up based on the evaluation of laboratory and imaging examination.
Study: NCT05841264

Intervention type: BEHAVIORAL
Intervention: good feeding, cleaning
Description: taking healthy food which contain minerals, vitamins essential for normal growth
Study: NCT05608213

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lenvatinib
Description: Lenvatinib (body weight ≥ 60 kg, 12mg P.O. QD; body weight \< 60 kg, 8mg P.O. QD) will be administered to the patients.
Study: NCT06079515

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Suprascapular Nerve Block
Description: SSNB group: The patients were asked to sit comfortably in the chair, and the transducer was placed on the spine of the scapula in the coronal plane and moved laterally to observe the supraspinatus notch and the suprascapular nerve. The injection mixture was applied in-plane with a 22-gauge, 90-mm needle on the suprascapular nerve, under the fascia of the supraspinatus muscle.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Suprascapular Nerve Block
Description: SSNB group: The patients were asked to sit comfortably in the chair, and the transducer was placed on the spine of the scapula in the coronal plane and moved laterally to observe the supraspinatus notch and the suprascapular nerve. The injection mixture was applied in-plane with a 22-gauge, 90-mm needle on the suprascapular nerve, under the fascia of the supraspinatus muscle.
Study: NCT05841264

Intervention type: BEHAVIORAL
Intervention: good feeding, cleaning
Description: taking healthy food which contain minerals, vitamins essential for normal growth

Intervention type: BEHAVIORAL
Intervention: good feeding, cleaning
Description: taking healthy food which contain minerals, vitamins essential for normal growth
Study: NCT06079515

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Intraarticular Shoulder Injection
Description: IAI group: The patients were asked to sit on the chair with their hands facing the opposite shoulder, and the transducer was placed slightly below the spina scapula. The humeral head was observed by moving laterally. The injection mixture was applied in-plane with a 22-gauge, 90-mm needle entering the skin at a 45-degree angle and applied to the joint space

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intraarticular Shoulder Injection
Description: IAI group: The patients were asked to sit on the chair with their hands facing the opposite shoulder, and the transducer was placed slightly below the spina scapula. The humeral head was observed by moving laterally. The injection mixture was applied in-plane with a 22-gauge, 90-mm needle entering the skin at a 45-degree angle and applied to the joint space
Study: NCT04630821

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dilute Sodium Hypochlorite solution
Description: Subjects will be treated with the dilute bleach compresses daily for the first 3 weeks of therapy.~While these subjects are undergoing radiation therapy, they will be assessed weekly before the day's compress treatment by a physician investigator on the study team. Subjects will be evaluated and photographs will also be taken at study visits 1-3. The subjects will also complete a subject questionnaire addressing patient-reported outcomes at baseline and each weekly check-in during these two weeks. They will be also interviewed about ease of use and treatment tolerability. Subjects will complete interview questions at the end of the study to determine if they would continue the treatment and any obstacles or barriers.
Study: NCT05550285

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: orbital floor recontriction
Description: Guided Calvarial Graft Harvesting vs 3D Printed Titanium mesh
Study: NCT06026007

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: advices
Description: each pregnant woman was advices how to elevate her legs and daily positions to elevate edema

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: advices
Description: each pregnant woman was advices how to elevate her legs and daily positions to elevate edema

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: advices
Description: each pregnant woman was advices how to elevate her legs and daily positions to elevate edema

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional physical therapy
Description: each pregnant woman was advised about daily routine in addition to circulatory exercise

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acupressure
Description: each pregnant woman was advised about daily routine in addition to acupressure therapy
Study: NCT05611099

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dreem 3 System vs WatchPAT One
Description: Dreem 3 System and WatchPAT One will be worn simultaneously during 3 nights by each study participant, in order to compare the TST automatically outputted by both devices.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usability Questionnaire
Description: After having undergone the 3 nights of measurement, an end of Study Questionnaire will be performed on a separate day to obtain Usability feedback from participants who have undergone simultaneous recordings with the Dreem 3 + WatchPAT devices.
Study: NCT04703322

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pexidartinib
Description: 400 mg twice daily for a total daily dose of 800 mg (each capsule contains 200 mg of pexidartinib for oral administration)
Study: NCT05484180

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: training and counseling supported guided imagery application
Description: After the preparation process, as a nursing attempt to the individuals in the experimental group; Training and consultancy supported guided imagery based on the health promotion model will be implemented. This initiative; It will take a total of 12 weeks, including 6 weeks of training program and 6 weeks of counseling program and guided imagery.
Study: NCT05444010

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: mandala painting
Description: nurse painted mandala for relaksing
Study: NCT06395545

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electronic injector
Description: At room temperature, 1% lidocaine combined with 1:100,000 epinephrine was used as a local anesthesia. The electronic constant-speed injector, i-JECT® (MediHub Inc., Gyeonggi-do, Korea) (Figure 1) was used, and the injection speed of the injector was set at level 1 (0.25 mL/s) or level 2 (0.4 mL/s). The injection site in a patient was divided into two sides (left and right). The method of local infiltration (manual or using the electronic injector) was randomly assigned to each side of the surgical field, and 2.5 cc (0.5 cc at five separate areas) of local anesthetic was injected individually using a 5 cc syringe with a 31-gauge needle. All injections were administered by a single surgeon (Sung Joo Tommy Hwang) to reduce inter-operator variation.
Study: NCT04779125

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Gluteus plasty enhanced with Progrip self gripping mesh
Description: Intervention group will be compared to historical patients in a case-control setting. Intervention group will have a mesh enhanced gluteus plasty made to reconstruct perineum after abdominoperineal resection.
Study: NCT06066164

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Transcranial magnetic stimulation (TMS)
Description: Trans-cranial magnetic stimulation (TMS) is a safe and painless technique for evoking activity in neurons in the human brain through the intact scalp and skull To measure cortical excitability

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcranial magnetic stimulation (TMS)
Description: Trans-cranial magnetic stimulation (TMS) is a safe and painless technique for evoking activity in neurons in the human brain through the intact scalp and skull To measure cortical excitability

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcranial magnetic stimulation (TMS)
Description: Trans-cranial magnetic stimulation (TMS) is a safe and painless technique for evoking activity in neurons in the human brain through the intact scalp and skull To measure cortical excitability
Study: NCT06145672

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: follicular unit extraction and implantaion
Description: extract hair follicles as grafts from donor area and implant them in recipient area

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: follicular unit extraction and implantaion
Description: extract hair follicles as grafts from donor area and implant them in recipient area
Study: NCT06264414

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DTT106
Description: oral route

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dutasteride-Tamsulosin
Description: oral route
Study: NCT05947175

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Vertebral bone marrow (vBMA) clot
Description: The clotted vBMA will be obtained from vertebral bone marrow aspirate.The vBMA clot contain mesenchymal stem cells (MSCs), growth factors, platelet and osteogenic and anti-inflammatory mediators.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Bone allograft chips
Description: Bone allograft chips will be obtained from Musculoskeletal Tissue Bank at IRCCS Istituto Ortopedico Rizzoli.
Study: NCT06438068

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Modern Colon Hydrotherapy plus probiotic product intake
Description: Colonic cleansing through 3 interventions of Modern Colon Hydrotherapy separated by 48 hours. In addition, a daily intake of a product with prebiotic and prebiotic properties for 30 days.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Modern Colon Hydrotherapy plus probiotic product intake
Description: Colonic cleansing through 3 interventions of Modern Colon Hydrotherapy separated by 48 hours. In addition, a daily intake of a product with prebiotic and prebiotic properties for 30 days.
Study: NCT04965129

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Drug: Placebo olive oil pill manufactured to mimic fish oil. Other Names: • Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fish oil
Description: All subjects will be given fish oil with a dose of of 2.100 mg of EPA and 924 mg of DHA, in four tablet twice daily for four mounths.
Study: NCT04581733

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MT1621
Description: All patients will receive MT1621 up to a target dose of 400 mg/kg/day each dC and dT, as tolerated.
Study: NCT05237453

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Photons
Description: MR-guided adaptive radiotherapy
Study: NCT06603558

Intervention type: DRUG
Intervention: Atogepant
Description: Oral Tablet
Study: NCT04930965

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Community health worker engagement
Description: 3-4 in-person or virtual engagements (individual or group sessions) over 1 month, each engagement lasting 30 minutes to 1 hour
Study: NCT06293677

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dosage Adjustment Rules for Augmented Renal Clearance (DAR-ARC) for piperacillin-tazobactam and meropenem
Description: Meropenem dosages according to eGFR \[mL/min/1.73 m²\] :~eGFR 120-149 : 40 mg/kg q6 h eGFR 150-199 : 30 mg/kg q4h eGFR 200-299 : 40 mg/kg q4h eGFR \&amp;gt;/= 300 : 40 mg/kg q4h~Piperacillin-tazobatam dosages according to eGFR \[mL/min/1.73 m²\] :~eGFR 120-149 : 150 mg/kg q6 h eGFR 150-199 : 120 mg/kg q4h eGFR 200-299 : 150 mg/kg q4h eGFR \&amp;gt;/= 300 : 180 mg/kg q4h~The maximum doses for the antibiotic prescription before the first drug monitoring will be 2gr of MER every 4 hours and 4gr of PIP every 4 hours.~The duration of infusion will be set to 2 h.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard dosages of piperacillin-tazobactam or meropenem
Description: Meropenem dosages according to eGFR \[mL/min/1.73 m²\] :~eGFR\> 50 : 40mg/kg q8h eGFR 25-49 : 40mg/kg q12h eGFR 15-24 : 20mg/kg q12h~Piperacillin-tazobactam :~eGFR \>50 : 100mg/kg q6h eGFR 20-49 : 50mg/kg q6h eGFR 15-29 : 50 mg/kg q8h

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard dosages of piperacillin-tazobactam or meropenem
Description: Meropenem dosages according to eGFR \[mL/min/1.73 m²\] :~eGFR\> 50 : 40mg/kg q8h eGFR 25-49 : 40mg/kg q12h eGFR 15-24 : 20mg/kg q12h~Piperacillin-tazobactam :~eGFR \>50 : 100mg/kg q6h eGFR 20-49 : 50mg/kg q6h eGFR 15-29 : 50 mg/kg q8h
Study: NCT05364229

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: MR-guided Radiotherapy Boost
Description: IMRT/VMAT prostate whole gland SBRT to 30 Gy in 5 fractions. MRL focal boost of 15 Gy in 1 fraction will be delivered either before or after whole gland SBRT.
Study: NCT05449509

Intervention type: DIAGNOSTIC_TEST
Intervention: Abdominal aortic Duplex ultrasound
Description: All patients will undergo bedside Duplex ultrasound in order to measure infrarenal abdominal aortic diameter.

Intervention type: DIAGNOSTIC_TEST
Intervention: Abdominal aortic Duplex ultrasound
Description: All patients will undergo bedside Duplex ultrasound in order to measure infrarenal abdominal aortic diameter.
Study: NCT05678946

Intervention type: OTHER
Intervention: Integrated face-to-face rehabilitation and telerehabilitation
Description: Kela´s integrated face-to-face rehabilitation and telerehabilitation services for family caregivers include two 5-day periods of face-to-face rehabilitation and a 12-week telerehabilitation period between them. It is for those over the age of 18 who work as family caregivers on a daily basis and need support, tools, and coaching to understand and overcome the challenges posed by the care situation. Individual goals based on the GAS method are set, evaluated, and adjusted during the rehabilitation. The service, provided free of charge, is carried out in a Finnish rehabilitation centre and online over a period of 8 months, and it is implemented by a multidisciplinary team of rehabilitation experts. During the 12-week telerehabilitation period, the service providers utilise The Own Path, an acceptance and commitment therapy -based guided web intervention found beneficial for older Finnish family caregivers (Lappalainen et al. 2021). Telerehabilitation is independent of time and place.

Intervention type: OTHER
Intervention: Social Holidays
Description: MTLH's Social Holidays for family caregivers are 5-day holidays in a Finnish hotel, spa, sports institute, or rehabilitation centre. The theme, content, and level of available assistance in Social Holidays vary, and the rehabilitation concept is lighter than that of Kela's rehabilitation services. Social Holidays include full-board accommodation and holiday activities, e.g. lectures, group discussions, instructed exercise, and a pampering treatment. MTLH organises Social Holidays for family caregivers as well as family caregivers and care recipients. The participants cover their travel expenses and pay a fixed sum of €125. Other than that, Social Holidays are provided free of charge. Social Holidays are intended for family caregivers who need recreational activities, rest, and peer support.

Intervention type: OTHER
Intervention: Face-to-face rehabilitation
Description: Kela's rehabilitation services for family caregivers and the care recipients include three 5-day periods of face-to-face rehabilitation, which are carried out in a Finnish rehabilitation centre over a 10-month period and implemented by a multidisciplinary team of rehabilitation experts. The rehabilitation services for family caregivers and the care recipients are provided free of charge. The service is intended for persons over the age of 18 who work as family caregivers on a daily basis with or without family caregiver support and who need support, tools, and coaching to understand and overcome the challenges posed by the care situation. Individual goals based on the GAS method are set, evaluated, and adjusted during the rehabilitation.
Study: NCT06663449

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: subcostal transversus abdominis plane block
Description: subcostal transversus abdominis plane block will be performed using 20 mL of 0.25 bupivacaine

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: erector spinae plane block
Description: erector spinae plane block will be performed using 20 mL of 0.25 bupivacaine
Study: NCT06591780

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clinical Evaluation
Description: A clinical evaluation occurs at the first study session. The clinical evaluation assesses walking function and mobility, lower extremity, sensation, health-related quality of life (HRQoL) and foot function.~Session 2 will be a dynamometer-based evaluation of passive ankle stiffness and a 3-dimensional gait analysis to evaluate baseline biomechanics. During Session 3, real-time biofeedback conditions will be used to measure the immediate effects on walking function.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Plantar Pressure Biofeedback Gait Training
Description: Participants will complete a 3-dimensional gait evaluation prior to training, after a 6-minute control bout without biofeedback, and following three 6-minute biofeedback training bouts (total 18-minutes). Individualized biofeedback targets will be calculated from each participant's immediate biofeedback session to best minimize plantar pressure whilst maintaining or enhancing propulsion. Audio-visual biofeedback is provided using a screen placed in front of the treadmill and a speaker. For plantar pressure biofeedback, a visual display of a foot with a colored heat map represents the current plantar pressure, in addition to bar graphs representing real-time movement of plantar pressure in specific areas of the foot. A target is provided using the heat map colors of red and target line on the bar graph. Participants are informed that the target is a measurement of the pressure under their foot, and their goal is to decrease pressure to achieve their target

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Propulsion Biofeedback Gait Training
Description: Participants will complete a 3-dimensional gait evaluation prior to training, after a 6-minute control bout without biofeedback, and following three 6-minute biofeedback training bouts (total 18-minutes). Individualized biofeedback targets will be calculated from each participant\&#39;s immediate biofeedback session to best minimize plantar pressure whilst maintaining or enhancing propulsion. Audio-visual biofeedback is provided using a screen placed in front of the treadmill and a speaker. For propulsion biofeedback, a visual display with a marker represents the current propulsion (peak AGRF) and a target provided to modulate propulsion. Participants are informed that the marker is a measurement of how hard they are pushing the ground backward, and their goal is to push-off more to achieve their target.
Study: NCT06333548

Intervention type: DIAGNOSTIC_TEST
Intervention: Appropriate for gestational age , small for gestational age, large for gestational age, Baby of mother diagnosed with GDM
Description: No intervention

Intervention type: DIAGNOSTIC_TEST
Intervention: Appropriate for gestational age , small for gestational age, large for gestational age, Baby of mother diagnosed with GDM
Description: No intervention

Intervention type: DIAGNOSTIC_TEST
Intervention: Appropriate for gestational age , small for gestational age, large for gestational age, Baby of mother diagnosed with GDM
Description: No intervention

Intervention type: DIAGNOSTIC_TEST
Intervention: Appropriate for gestational age , small for gestational age, large for gestational age, Baby of mother diagnosed with GDM
Description: No intervention
Study: NCT05710952

Intervention type: DEVICE
Group type: OTHER
Intervention: Review by Modjaw
Description: A review by Modjaw's will be done before the braces treatment and after.
Study: NCT05587803

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Neurowave and Sedline indices in view
Description: 3 additional electrodes are attached on the patients forehead. After electrode placement, the indices of both the SEDLINE device and the NEUROWAVE device are noted every 5 seconds for 1 minute
Study: NCT04728399

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Experimental group
Description: Take 1 bag a day with warm boiling water. Intervention: 2g Soybean peptide, 3g CLA and ng protein. They will complete all baseline, 12-weeks, and 24-weeks visits

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Control group
Description: Take 1 bag a day with warm boiling water. Intervention: 2g+N protein and 3g Soybean oil. They will complete all baseline, 12-weeks, and 24-weeks visits
Study: NCT06552338

Intervention type: OTHER
Intervention: Observational
Description: No intervention. Study is observational

Intervention type: OTHER
Intervention: Observational
Description: No intervention. Study is observational

Intervention type: OTHER
Intervention: Observational
Description: No intervention. Study is observational

Intervention type: OTHER
Intervention: Observational
Description: No intervention. Study is observational